Controlling illumination and brain temperature in optogenetic activation
Patent Information
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- MODULIGHT BIO LTD
- Filing Date
- 2024-06-02
- Publication Date
- 2026-04-22
AI Technical Summary
Current neurological treatments, such as electrical stimulation and medication, lack precise spatial control and often result in adverse effects, while optogenetic methods offer improved precision but require precise temperature control to prevent tissue damage during optogenetic activation in the brain.
A device implanted in the brain that uses a resonance circuit to adjust the intensity of electrical power based on temperature changes, incorporating a magnetic field converter and light-emitting diodes to apply controlled illumination while maintaining temperature within a safe range, utilizing a processor for closed-loop temperature control.
Enables precise optogenetic activation with minimized tissue heating, reducing adverse effects and improving treatment efficacy for neurological conditions like Parkinson's disease and epilepsy by maintaining temperature within a safe 2°C limit.
Smart Images

Figure IB2024055378_19122024_PF_FP_ABST